Compare Abeona Therapeutics Inc (ABEO) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.35. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | EMLC | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Fixed Income |
52-Week High | $7.23 | $26.59 |
52-Week Low | $4.17 | $24.83 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
EMLC trades at $25.59 with a modest 0.51% daily gain, showing bullish technical momentum with strong moving average support. The ETF maintains a consistent dividend distribution pattern with recent $0.14 payouts, while technical indicators show mixed signals with RSI in neutral territory. Emerging market debt remains in focus as investors seek yield above Treasury bonds amid shifting global monetary policy.
The outlook for EMLC hinges on Federal Reserve policy and emerging market stability. The 6.09% yield provides income appeal, but currency risk and short interest growth present challenges. Institutional demand for EM debt is rising, though sustainability concerns warrant monitoring given the 73% short interest surge reported in April 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
